Manufacturer of Controlled Substances Registration: Stepan Company, 22121-22122 [2016-08576]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 72 / Thursday, April 14, 2016 / Notices
The last notification was filed with
the Department on October 22, 2015. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on December 7, 2015 (80 FR 76042).
Register pursuant to section 6(b) of the
Act on March 9, 2016, (81 FR 12529).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2016–08580 Filed 4–13–16; 8:45 am]
[FR Doc. 2016–08584 Filed 4–13–16; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE P
BILLING CODE P
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—National Armaments
Consortium
DEPARTMENT OF JUSTICE
Antitrust Division
mstockstill on DSK4VPTVN1PROD with NOTICES
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Cooperative Research
Group on Chede–VII
Notice is hereby given that, on March
15, 2016, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Southwest Research
Institute—Cooperative Research Group
on CHEDE–VII (‘‘CHEDE–VII’’) has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
changes in its membership. The
notifications were filed for the purpose
of extending the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances. Specifically,
Detroit Diesel Corporation, Detroit, MI;
Mahle Engine Components USA, Inc.,
Farmington Hills, MI; Volvo Powertrain
North America, Hagerstown, MD; Tata
Motors Ltd., Mumbai, INDIA;
Convergent Science, Madison, WI; and
PACCAR C/O DAF Trucks N.V.,
Eindhoven, NETHERLANDS, have been
added as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and CHEDE–VII
intends to file additional written
notifications disclosing all changes in
membership.
On January 6, 2016, CHEDE–VII filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on February 2, 2016, (81
FR 5484).
The last notification was filed with
the Department on February 10, 2016. A
notice was published in the Federal
VerDate Sep<11>2014
17:56 Apr 13, 2016
Jkt 238001
Notice is hereby given that, on March
15, 2016, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), National Armaments
Consortium (‘‘NAC’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Akita Innovations, LLC,
North Billerica, MA; American
Engineering & Manufacturing, Inc.,
Elyria, OH; American Rheinmetall
Munitions, Inc., Stafford, VA; Aria
Microwave Systems, Inc., Teaneck, NJ;
BEAM Engineering for Advanced
Measurements, Orlando, FL; Bradshaw
Engineering and Technical Services,
LLC, Union Grove, AL; C–2 Innovations,
Inc., Stow, MA; CIRTEMO, LLC, Cayce,
SC; Cummings Aerospace, Inc.,
Huntsville, AL; Elbit Systems of
America, LLC, Fort Worth, TX;
Electronics & Manufacturing Co., LLC,
Columbia, MO; Elmet Technologies,
LLC, Lewiston, ME; Evigia Systems,
Inc., Ann Arbor, MI; Fairlead Precision
Manufacturing & Integration, LLC,
Portsmouth, VA; Fiocchi of America,
Ozark, MO; GECO, Inc., Mesa, AZ;
General Dynamics C4 Systems, Inc.,
Scottsdale, AZ; Hardigg Industries, Inc.,
South Deerfield, MA; Integrated Global
Insights, LLC, Burke, VA; Integration
Innovation, Inc. (i3), Huntsville, AL;
Kratos Defense & Rocket Support
Services, Inc., King George, VA; L–3
Electron Devices, Williamsport, PA;
Lancer Systems, LP, Quakertown, PA;
Leigh Aerosystems Corporation,
Carlsbad, CA; Logikos, Inc., Fort Wayne,
IN; Magnesium Elektron North
American, Inc., Madison, IL; Materion
Brush, Inc., Elmore, OH; MBDA
Incorporated, Arlington, VA; Molex,
LLC, Lisle, IL; OMNI Consulting
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
22121
Solutions, LLC, El Segundo, CA; Orion
Munitions Development, LLC,
Gladstone, MO; pH Matter, LLC,
Columbus, OH; PolyPlus Battery
Company, Berkeley, CA; Polysciences,
Inc., Warrington, PA; Pyrolink
International Inc., Alexandria, VA;
Quantum Dimension, Inc., Huntington
Beach, CA; Radiation Monitoring
Devices, Inc., Watertown, PA; Saab
Defense and Security USA, LLC, East
Syracuse, NY; SimVentions, Inc.,
Fredericksburg, VA; Southern Research
Institute, Birmingham, AL; STS
Technologies, LLC, Mahwah, NJ; The
Regents of the University of California,
Irvine, Irvine, CA; Vadum, Inc., Raleigh,
NC; ViaSat, Inc., Gilbert, AZ; and
Wilcox Industries Corp, Newintong, PA,
have been added as parties to this
venture.
Also, Applied Thin Films, Inc.,
Skokie, IL; Fluorochem, Inc., Azusa, CA;
Prime Photonics, LC, Blacksburg, VA;
Safety Consulting Engineers,
Schauraburg, IL; Saint-Gobain Ceramics
& Plastics, Inc., Milford, NH; and
Soligie, Inc., Savage, MN, have
withdrawn as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and NAC intends
to file additional written notifications
disclosing all changes in membership.
On May 2, 2000, NAC filed its original
notification pursuant to Section 6(a) of
the Act. The Department of Justice
published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on June 30, 2000 (65 FR 40693).
The last notification was filed with
the Department on November 10, 2015.
A notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on December 23, 2015 (80 FR
79931).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2016–08577 Filed 4–13–16; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Manufacturer of Controlled
Substances Registration: Stepan
Company
ACTION:
Notice of registration.
Stepan Company applied to
be registered as a manufacturer of
SUMMARY:
E:\FR\FM\14APN1.SGM
14APN1
22122
Federal Register / Vol. 81, No. 72 / Thursday, April 14, 2016 / Notices
certain basic classes of controlled
substances. The Drug Enforcement
Administration (DEA) grants Stepan
Company registration as a manufacturer
of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated April 14, 2015, and published in
the Federal Register on April 22, 2015,
80 FR 22555, Stepan Company, Natural
Products Department, 100 W. Hunter
Avenue, Maywood, New Jersey 07607
applied to be registered as a
manufacturer of certain basic classes of
controlled substances. No comments or
objections were submitted for this
notice.
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of Stepan Company to
manufacture the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of the following basic
classes of controlled substances:
Controlled substance
Schedule
Cocaine (9041) .............................
Ecgonine (9180) ...........................
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before June 13, 2016.
DEPARTMENT OF JUSTICE
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
[Docket No. 16–7]
ADDRESSES:
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on January
13, 2016, Patheon API Manufacturing,
Inc., 309 Delaware Street, Building
1106, Greenville, South Carolina 29605
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
II
II
Controlled substance
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Dated: April 4, 2016
Louis J. Milione,
Deputy Assistant Administrator.
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Noroxymorphone (9668) ..............
Schedule
I
I
II
[Docket No. DEA–392]
The company plans to manufacture
the above-listed controlled substances
as Active Pharmaceutical Ingredients
(API) for clinical trials.
In reference to drug codes 7360
(marihuana), and 7370 (THC), the
company plans to bulk manufacture
these drugs as synthetics. No other
activities for these drug codes are
authorized for this registration.
Bulk Manufacturer of Controlled
Substances Application: Patheon API
Manufacturing, Inc.
Dated: March 29, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–08576 Filed 4–13–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
mstockstill on DSK4VPTVN1PROD with NOTICES
Drug Enforcement Administration
[FR Doc. 2016–08569 Filed 4–13–16; 8:45 am]
ACTION:
Notice of application.
BILLING CODE 4410–09–P
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
DATES:
VerDate Sep<11>2014
17:56 Apr 13, 2016
Jkt 238001
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Drug Enforcement Administration
Rezik A. Saqer, M.D.; Decision and
Order
On October 1, 2015, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, issued an Order to
Show Cause to Rezik A. Saqer, M.D.,
(Respondent). The Show Cause Order
proposed the revocation of
Respondent’s DEA Certificates of
Registration BS4072637 and FS1975359,
pursuant to which he is authorized to
dispense controlled substances in
schedules II through V, as a practitioner,
at the respective registered locations of
11037 FM 1960 West, Suite B1,
Houston, Texas, and 3074 College Park
Drive, Conroe, Texas. Show Cause
Order, at 1. The Show Cause Order
further proposed the denial of any
applications to renew or modify either
registration, as well as the denial of any
other application for a DEA registration.
Id.
More specifically, the Show Cause
Order alleged that ‘‘[e]ffective
September 28, 2015, the Texas Medical
Board issued an Order of Temporary
Suspension . . . which suspended
[Respondent’s] medical license,’’ and
therefore, he is currently ‘‘without
authority to handle controlled
substances in Texas, the State in which
[he is] registered with’’ DEA. Id. at 2.
The Show Cause Order thus advised
Respondent that ‘‘DEA must revoke [his]
registrations based upon [his] lack of
authority to handle controlled
substances in the State of Texas.’’ Id.
(citing 21 U.S.C. 802(21), 823(f), and
824(a)(3)).
On October 2, 2015, a Diversion
Investigator served the Show Cause
Order by travelling to Respondent’s
registered location in Houston, and
leaving it with a medical assistant, who
provided a signed receipt for the Order.
Affidavit of DI, at 1. On November 5,
2015, Respondent, through his counsel,
requested a hearing on the allegations of
the Show Cause Order.1 The matter was
then placed on the docket of the Office
of Administrative Law Judges, and
1 While Respondent’s request was untimely,
Respondent’s counsel subsequently filed a motion
which established that his secretary had attempted
to file the hearing request by UPS overnight
delivery, but had provided an incorrect address.
DEA has previously held that this type of
inadvertence may establish ‘‘good cause’’ to excuse
an untimely hearing request, at least when the party
promptly moves to rectify the omission. Tony Bui,
75 FR 49979, 49980 (2010).
E:\FR\FM\14APN1.SGM
14APN1
]]>Agencies
[Federal Register Volume 81, Number 72 (Thursday, April 14, 2016)]
[Notices]
[Pages 22121-22122]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-08576]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Manufacturer of Controlled Substances Registration: Stepan
Company
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Stepan Company applied to be registered as a manufacturer of
[[Page 22122]]
certain basic classes of controlled substances. The Drug Enforcement
Administration (DEA) grants Stepan Company registration as a
manufacturer of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice dated April 14, 2015, and
published in the Federal Register on April 22, 2015, 80 FR 22555,
Stepan Company, Natural Products Department, 100 W. Hunter Avenue,
Maywood, New Jersey 07607 applied to be registered as a manufacturer of
certain basic classes of controlled substances. No comments or
objections were submitted for this notice.
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of Stepan Company to manufacture the
basic classes of controlled substances is consistent with the public
interest and with United States obligations under international
treaties, conventions, or protocols in effect on May 1, 1971. The DEA
investigated the company's maintenance of effective controls against
diversion by inspecting and testing the company's physical security
systems, verifying the company's compliance with state and local laws,
and reviewing the company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above-named company is granted registration as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Cocaine (9041)............................. II
Ecgonine (9180)............................ II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
Dated: April 4, 2016
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-08576 Filed 4-13-16; 8:45 am]
BILLING CODE 4410-09-P
